CPIC publishes guidelines for HLA-B*15:02 Genotype and Carbamazepine Use
The Clinical Pharmacogenomics Implementation Consortium (CPIC) has published guidelines for the use of genetic test results for HLA-B*15:02 and carbamazepine in Clinical Pharmacology and Therapeutics. In cases where a patient is known to carry at least one HLA-B*15:02 allele, the guideline recommends that the clinician use